Anti-osteoporotic Activity of Ethyl Cinnamate from Coix lacryma-jobi Targeting SOD and GPx Proteins
Article Sidebar
Main Article Content
Abstract
Free radicals, reactive oxygen species (ROS), and reactive nitrogen species (RNS) can trigger oxidative stress, known to be responsible for the downregulation of Superoxide Dismutase (SOD) and Glutathione Peroxidase (GPx), known endogenous antioxidants. Ethyl cinnamate is a bioactive component of Coix lacryma-jobi with strong antioxidant activity with a potential to suppress ROS which could be useful in the prevention of osteoporosis. Molecular docking is a cost-effective method to determine the biological activity of molecules through virtual interactions with related protein targets in biological systems. This study aimed to determine the antiosteoporotic activity of Ethyl cinnamate from hanjeli fruit using in silico methods. The 3D structures of the target proteins (SOD and GPx) were retrieved from the RCSB Protein Data Bank, while the ligand (Ethyl cinnamate) was obtained from GC-MS analysis of Coix lacryma-jobi extract. The proteins were prepared for docking using the Chimera 1.10.1 software, while the 3D structure of the ligand was optimised using the HyperChem 8 software. The molecular docking process was done using the Autodock 4.2 software. The results of the study indicated that Ethyl cinnamate interacted with putative sites of SOD and GPx proteins, with binding free energy of -0.75 and -1.61 kcal/mol, respectively. The results showed that Ethyl cinnamate from the hanjeli plant has the potential to neutralise free radicals through the upregulation of endogenous SOD and GPx responsible for the inhibition of oxidative stress implicated in bone resorption. This preliminary in silico study shows that Ethyl cinnamate has the potential to prevent oxidative stress and can be useful in the management of osteoporosis.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Hejazi J, Davoodi A, Khosravi M, Sedaghat M, Abedi V, Hosseinverdi S, Ehrampoush E, Homayounfar R, Shojaie L. Nutrition and osteoporosis prevention and treatment. Biomed. Res. Ther. 2020;7(4):3709-3720. https://doi.org/10.15419/bmrat.v7i4.598
Aji B, Wijayanti SP, Masfiah S, Anandari D, Chamchan C. Physical Functioning Among Community-Dwelling Elderly in Rural Indonesia. Community Health Equity Res. Policy. 2022; 42(4):375-380. https://doi.org/10.1177/0272684X211004927
Pazianas M, Miller PD. Osteoporosis and chronic kidney disease–mineral and bone disorder (CKD-MBD): back to basics. Am. J. Kidney Dis. 2021; 78(4):582-589. https://doi.org/10.1053/j.ajkd.2020.12.024
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2019;104(5):1595-1622. https://doi.org/10.1210/jc.2019-00221
Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int. J. Mol. Sci. 2019; 20(14):3576-3582. https://doi.org/10.3390/ijms20143576
Diningrat DS, Risfandi M, Harahap NS, Sari AN. Phytochemical screening and antibacterial activity Coix lacryma-jobi oil. J. Plant Biotechnol. 2020;47(1):100-106. https://doi.org/10.5010/JPB.2020.47.1.100
Diningrat DS, Sari AN, Harahap NS. Potential of Hanjeli (Coix lacryma-jobi) essential oil in preventing SARS-CoV-2 infection via blocking the Angiotensin Converting Enzyme 2 (ACE2) receptor. J. Plant Biotechnol. 2021;48(4):289-303. https://doi.org/10.5010/JPB.2021.48.4.289
Diningrat DS,Marwani E, Kusdianti. Antiacne and Antibacterial Bioactivity Properties of Teak (Tectona grandis) Flower Essential Oil. Trop J Nat Prod Res. 2023; 7(11):5195-5202. http://www.doi.org/10.26538/tjnpr/v7i11.24
Omata Y, Frech M, Lucas S, Primbs T, Knipfer L, Wirtz S, Kadono Y, Saito T, Tanaka S, Sarter K, Schett G. Type 2 innate lymphoid cells inhibit the differentiation of osteoclasts and protect from ovariectomy-induced bone loss. Bone. 2020; 136:115335-115342. https://doi.org/10.1016/j.bone.2020.115335
da Fonseca AM, Caluaco BJ, Madureira JM, Cabongo SQ, Gaieta EM, Djata F, Colares RP, Neto MM, Fernandes CF, Marinho GS, Dos Santos HS. Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking, and approach with molecular dynamics, RMSD, RMSF, H-bond, SASA and MMGBSA. Mol. Biotechnol. 2023; 25:1-5. https://doi.org/10.1007/s12033-023-00831-x
Zhang H, Liao L, Saravanan KM, Yin P, Wei Y. DeepBindRG: a deep learning based method for estimating effective protein–ligand affinity. PeerJ. 2019: 25:7: e7362- e7369. https://doi.org/10.7717/peerj.7362
Basu, A., Sarkar, A., & Maulik, U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci. Rep. 2020; 10(1), 1-15. https://doi.org/10.1038/s41598-020-74715-4
Diningrat, D. S., Harahap, N. S., Risfandi, M., & Sari, A. N. Antioxidant and antibacterial activities of Coix lacryma-jobi seed and root oil potential for meningitis treatment. Jordan J. Biol. Sci. 2021; 14(5), 881-887. https://doi.org/10.54319/jjbs/140501
Mammana S, Cavalli E, Gugliandolo A, Silvestro S, Pollastro F, Bramanti P, Mazzon E. Could the combination of two non-psychotropic cannabinoids counteract neuroinflammation? Effectiveness of cannabidiol associated with cannabigerol. Medicina. 2019; 55(11):747-757. https://doi.org/10.3390/medicina55110747
Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. J. Med. Virol. 2020; 92(9):1518-1524. https://doi.org/10.1002/jmv.25727
Wardana AP, Aminah NS, Fahmi MZ, Kristanti AN, Zahrah HI, Takaya Y, Choudary MI. Nanoencapsulation of Syzygium polycephalum extract using folate modified κ-carrageenan as vehicles for pronounced anticancer activity. Trop J Nat Prod Res. 2020;4(11):945-952.. https://doi.org/10.1016/j.aqrep.2022.101268
Meyer-Almes, F. J. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Comput. Biol. Chem. 2020; 88, 107351-107363. https://doi.org/10.1016/j.compbiolchem.2020.107351
Domínguez-Villa, F. X., Durán-Iturbide, N. A., & Ávila-Zárraga, J. G. Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl) indol-4-ones: Potential inhibitors of SARS CoV-2 main protease. Bioorg. Chem. 2021. 106; 104497-104502. https://doi.org/10.1016/j.bioorg.2020.104497
Zhang, D. H., Wu, K. L., Zhang, X., Deng, S. Q., & Peng, B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med. 2020: 18(2), 152-158. https://doi.org/10.1016/j.joim.2020.02.005
Aljahdali, M. O., Molla, M. H. R., & Ahammad, F. Compounds identified from marine mangrove plant (Avicennia Alba) as potential antiviral drug candidates against WDSV, an in-silico approach. Mar. Drugs. 2021: 19(5), 253-268. https://doi.org/10.3390/md19050253
Missioui, M., Said, M. A., Demirtaş, G., Mague, J. T., Al-Sulami, A., Al-Kaff, N. S., & Ramli, Y. A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1 (2H)-yl) acetyl) hydrazono) malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity. Arabian J. Chem. 2022; 15(2), 103595-103613. https://doi.org/10.1016/j.arabjc.2021.103595
Cheng, F.J., Huynh, T.K., Yang, C.S., Hu, D.W., Shen, Y.C., Tu, C.Y., Wu, Y.C., Tang, C.H., Huang, W.C., Chen, Y. & Ho, C.Y. Hesperidin is a potential inhibitor against SARS-CoV-2 infection. Nutrients. 2021; 13(8), 2800-2813. https://doi.org/10.3390/nu13082800